Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | COMT | P21964 | 3/20 | 0.52 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20100881 | 0.88 | COMT (0.67) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL20100894 | 0.88 | COMT (0.53) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL29493686 | 0.85 | FTO (0.67) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL20100867 | 0.85 | FTO (0.67) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL23255049 | 0.82 | ALDH1A1 (0.44) | FTOKMT2AMEN1ALDH1A1POLB | |
| SCHEMBL20100893 | 0.81 | COMT (0.78) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL23865303 | 0.79 | ALDH1A1 (0.41) | FTOKMT2AMEN1ALDH1A1POLB | |
| SCHEMBL20100889 | 0.78 | FTO (0.48) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL20100886 | 0.78 | FTO (0.69) | COMTFTOKMT2AMEN1MAPT | |
| SCHEMBL28715850 | 0.78 | FTO (0.78) | COMTFTOKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922316-B | FTO inhibitors | 北京生命科学研究所 | 2022-04-08 | — | — | CN | disclosed |
| US-20180118665-A1 | FTO Inhibitors | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118665-A1 | FTO Inhibitors | FTO, ALKBH3, ALKBH1 | COMT 9/4885FTO 1/4885KMT2A 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.